SCHOTT Pharma AG & Co. KGaA (ETR: 1SXP)

Market Cap	4.01B
Revenue (ttm)	948.56M
Net Income (ttm)	150.41M
Shares Out	150.61M
EPS (ttm)	1.00
PE Ratio	26.67
Forward PE	26.25
Dividend	0.15 (0.57%)
Ex-Dividend Date	n/a

Volume	36,176
Open	26.24
Previous Close	26.22
Day's Range	26.24 - 27.04
52-Week Range	25.54 - 43.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 12, 2024

About SCHOTT Pharma AG & Co. KGaA

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,646
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 1SXP

Financial Performance

In 2023, SCHOTT Pharma AG & Co. KGaA's revenue was 898.60 million, an increase of 9.43% compared to the previous year's 821.14 million. Earnings were 151.84 million, an increase of 21.11%.